Lee Health develops natural capsule for effective Heart care

The soft gel capsule, which was developed after an extensive research in cardiovascular diseases, contains bioactive compounds from aged garlic extract, gama oryzanol, phytosterol, lycopene, nano curcumin, fenugreek and piperine, said Alla Leela Rani, Director, Lee Health Domain.

“The bioactive compounds used in Lyphosterol are highly potent and effective in balancing cholesterol and triglyceride levels. They remove soft plaque in the arteries for stabilisation of irregular heartbeats. Moreover, these compounds protect the body against the damage from free radicals and also reduce the risk of heart disease,” explained Leela Rani, company’s Director.

Lyphosterol is available for sale on Amazon, Lee Health Domain portal and leading pharmacies.

Leela Rani further said that in olden days, people aged over 60 years used to suffer heart attacks. “Now, that scenario changed, especially post the Covid pandemic. There has been rapid surge in deaths due to sudden heart attacks and younger people are also falling prey to cardiac arrests now,” she added.

According to her, there are many factors that contribute to sudden heart failures. “Major reasons are sedentary life style, irregular eating habits and stress. Experts also suspect that indiscriminate use of medicines during Covid is also one of the factors for heart attacks,” Leela Rani observed.

Lee Health Domain manufactures nutraceutical products from natural herbs that provide solutions to problems related to lifestyle-related health problems, joint pains, eye diseases, cold, cough, etc. It developed a host of products after extensive research. There is a huge demand for its products not only in India, but also overseas. Some of products in its line-up include Smoothwalk, Spinocort, Immunolact, D-Macula, Free Menocycle, Active-Plus, Actokin, Steam Mantra and Vasa Tulsi Plus. The company also manufactures skin, hair and nails care products under Lee Natural Care brand.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?